GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clarity Pharmaceuticals Ltd (ASX:CU6) » Definitions » PensionAndRetirementBenefit

Clarity Pharmaceuticals (ASX:CU6) PensionAndRetirementBenefit : A$0.00 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Clarity Pharmaceuticals PensionAndRetirementBenefit?

Clarity Pharmaceuticals's PensionAndRetirementBenefit for the quarter that ended in Dec. 2023 was A$0.00 Mil.

Clarity Pharmaceuticals's quarterly PensionAndRetirementBenefit increased from Dec. 2022 (A$0.00 Mil) to Jun. 2023 (A$0.18 Mil) but then declined from Jun. 2023 (A$0.18 Mil) to Dec. 2023 (A$0.00 Mil).

Clarity Pharmaceuticals's annual PensionAndRetirementBenefit increased from . 20 (A$0.00 Mil) to Jun. 2022 (A$0.08 Mil) and increased from Jun. 2022 (A$0.08 Mil) to Jun. 2023 (A$0.18 Mil).


Clarity Pharmaceuticals PensionAndRetirementBenefit Historical Data

The historical data trend for Clarity Pharmaceuticals's PensionAndRetirementBenefit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clarity Pharmaceuticals PensionAndRetirementBenefit Chart

Clarity Pharmaceuticals Annual Data
Trend Jun22 Jun23
PensionAndRetirementBenefit
0.08 0.18

Clarity Pharmaceuticals Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
PensionAndRetirementBenefit Get a 7-Day Free Trial - 0.08 - 0.18 -

Clarity Pharmaceuticals PensionAndRetirementBenefit Calculation

PensionAndRetirementBenefit is the carrying amount as of the balance sheet date of the portion of the obligations recognized for the various benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement.


Clarity Pharmaceuticals (ASX:CU6) Business Description

Traded in Other Exchanges
Address
4 Cornwallis Street, National Innovation Centre, Eveleigh, Sydney, NSW, AUS, 2015
Clarity Pharmaceuticals Ltd is a clinical-stage radiopharmaceutical company developing next-generation theranostic (therapy and imaging) products, based on its platform SAR Technology. The SAR technology is ideally suited for use with copper isotopes, enabling superior imaging and therapeutic characteristics of radiopharmaceutical products and addressing the current manufacturing and logistical limitations in the growth of the radiopharmaceutical sector in oncology.

Clarity Pharmaceuticals (ASX:CU6) Headlines

No Headlines